Clean Science and Technology (CLEAN) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 delivered resilient performance amid global trade volatility, with record-high consolidated EBITDA margin of 46.4% and strong HALS series sales.

• Consolidated revenue for Q1 FY26 was INR 243 crore, up 8% year-over-year, and consolidated EBITDA was INR 100 crore.

• FY2025 saw record-high consolidated revenue of INR 950 crore, with over 25% from new product launches and 63% of revenue from exports.

• Board approved unaudited standalone and consolidated financial results for Q1 FY2025, with no material misstatements reported by auditors.

• 22nd AGM scheduled for September 11, 2025, with final dividend to be paid on September 26, 2025.

Financial highlights

• Q1 FY26 consolidated revenue was INR 243 crore, up 8% year-over-year; consolidated EBITDA was INR 100 crore with a 46.4% margin.

• Q1 FY26 consolidated PAT was INR 70 crore, up 6% year-over-year, with PAT margin at 28.9%.

• Standalone revenue for Q1 FY26 was INR 217 crore, with standalone EBITDA at INR 101 crore and margin over 46%.

• FY2025 revenue CAGR was 16%, EBITDA CAGR 11%, and PAT CAGR 10%.

• Company maintains a debt-free balance sheet.

Outlook and guidance

• Newer HALS grades and performance chemicals to be commercialized over the next two quarters, expected to positively impact margins.

• EBITDA growth guidance moderated to 15%-18% for FY26, with more clarity expected by Q2 end.

• Revenue acceleration expected from new launches, with addressable market expanding by over $1.7 billion in the next three quarters.

• Strategic focus on ESG, sustainability, and expanding both domestically and globally.

• Water trials for a new performance chemical to begin in August; capex for another new chemical progressing as planned.